FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• The transcription factor FOXO3 is involved in cell survival and immune responses.
• Its role in modulating pro-inflammatory cytokine production by dendritic cells (DCs) is known, but molecular mechanisms remain unclear.
• Cross-talk between FOXO3 and NF-κB pathways suggests regulatory interactions in inflammation.

Purpose of the Study:

• To elucidate the molecular mechanisms by which FOXO3 influences inflammatory responses in human monocyte-derived dendritic cells (MDDCs).
• To investigate the regulation of FOXO3 activity by kinases involved in the interferon-beta (IFN-β) pathway.
• To identify FOXO3 as a regulatory checkpoint in Toll-like receptor 4 (TLR4) signaling.

Main Methods:

• Human monocyte-derived dendritic cells (MDDCs) were utilized.
• Experiments involved stimulation with Toll-like receptor 4 (TLR4) agonists.
• Analysis of signaling intermediates including NF-κB and IRFs, and expression of IFN-β.
• Investigation of the role of IKK-ε kinase in FOXO3 regulation.

Main Results:

• FOXO3 antagonizes signaling intermediates downstream of TLR4, including NF-κB and IRFs, thereby inhibiting IFN-β expression in MDDCs.
• The kinase IKK-ε phosphorylates and inactivates FOXO3 in response to TLR4 activation.
• This identifies FOXO3 as a novel checkpoint controlled by IKK-ε in the regulation of IRF activation and IFN-β production.

Conclusions:

• FOXO3 acts as a negative regulator of TLR4-induced inflammatory responses, specifically IFN-β production, in dendritic cells.
• IKK-ε-mediated inactivation of FOXO3 is a key regulatory mechanism controlling the inflammatory signaling cascade.
• These findings provide new insights into the role of FOXO3 in immune response control and highlight a novel regulatory pathway.